首页> 外文期刊>European Journal of Pharmacology: An International Journal >9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
【24h】

9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.

机译:9-(氨基甲基)-9,10-二氢蒽是一种新颖且不太可能的5-HT2A受体拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Structural elaboration of phenylethylamine to 9-(aminomethyl)-9,10-dihydroanthracene (AMDA) produces an agent with high affinity (Ki = 9.5-21 nM) at 5-HT2A receptors. It was shown that AMDA acts as a 5-HT2A receptor antagonist. The structure and molecular geometry of AMDA are not consistent with existing pharmacophore models for 5-HT2A receptor antagonist activity. Thus, AMDA may be a structurally novel parent of a new class of 5-HT2A receptor antagonists that binds to the receptor in a unique fashion that is distinct from the binding topology of existing 5-HT2A receptor antagonists.
机译:苯乙胺对9-(氨基甲基)-9,10-二氢蒽(AMDA)的结构修饰产生了对5-HT2A受体具有高亲和力的试剂(Ki = 9.5-21 nM)。结果表明,AMDA可以作为5-HT2A受体拮抗剂。 AMDA的结构和分子几何形状与现有的5-HT2A受体拮抗剂活性药效团模型不一致。因此,AMDA可能是新型5-HT 2A受体拮抗剂的结构新颖的亲本,其以不同于现有5-HT 2A受体拮抗剂的结合拓扑的独特方式与受体结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号